Actemra 162 mg/.9mL
tocilizumab · INJECTION, SOLUTION · Genentech, Inc.
No Recall History
Plain English
Actemra is a injection, solution containing tocilizumab at 162 mg/.9mL, taken subcutaneous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Actemra
- Generic Name
- tocilizumab
- NDC Code (Product)
50242-138- Manufacturer
- Genentech, Inc.
- Strength
- 162 mg/.9mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125472
- Drug Class
- Interleukin-6 Receptor Antagonist [EPC]
- Marketing Start
- 10/21/2013
Recall History
No Recall HistoryFrequently Asked Questions
What is Actemra used for?
Actemra contains tocilizumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Actemra a controlled substance?
Actemra is not classified as a controlled substance by the DEA.
What is the generic name for Actemra?
The generic name for Actemra is tocilizumab. There are 11 other brand versions of tocilizumab.
What is the NDC code for Actemra 162 mg/.9mL?
The NDC (National Drug Code) for Actemra 162 mg/.9mL is 50242-138, listed by Genentech, Inc..